Ulipristal Acetate Effectively Medically Manages Symptomatic Leiomyomatous Uteri
Journal Title: International Journal of Reproduction, Fertility & Sexual Health (IJRFSH) - Year 2017, Vol 4, Issue 1
Abstract
Background: Symptomatic leiomyomatous uteri affect about 30% of women. Associated anemia, dysmenorrhea, dyspareunia, heavy menstrual bleeding, and mass effects cause quality of life decrements. The 5-year levonorgestrel intrauterine device (5yr-IUD) has been a mainstay of medical management for symptomatic leiomyomata. If approved, Ulipristal acetate (UPA),which entered the European and Canadian markets in 2012 and 2013, could change medical management of symptomatic leiomyomata in the United States. Methods: PubMed search for the term “ulipristal acetate treatment fibroids” yielded five included articles. Hand search provided nine additional articles. Results: The 5yr-IUD achieves maximal amenorrhea in 70% of users at 3 months. Dysmenorrhea improves in 84% of 5yr- IUD users. A Phase III trial with 451 participants compared UPA 5 and 10 mg over four 12-week treatment cycles. At the study end, menstruation was controlled in up to 77.5% of participants, with 70% or more participants in each group achieving amenorrhea. Combined median leiomyoma volume reduction for the three largest leiomyomata reached 67.4%. Median health related QOL scores decreased from 56.9 and 55.2 respectively to 20.7 and 15.5 respectively after the fourth treatment cycle. Conclusion: UPA offers onset amenorrhea within 6 days irrespective of dose, whereas the 5yr-IUD may take 3-months to achieve amenorrhea. UPA decreases leiomyomata volume up to 65% within 1-year, but, the 5yr-IUD does not reduce leiomyomata volume. The 5yr-IUD provides simultaneous contraception, whereas UPA requires separate contraception. As there are no significant benefits to higher dose treatment, UPA 5 mg should have a place in gynecologic clinical practice.
Authors and Affiliations
Oroma B. Nwanodi
Keywords
Related Articles
- EP ID EP326239
- DOI 10.19070/2377-1887-1700016
- Views 89
- Downloads 0
Dichorio-Triamniotic Triplet Pregnancy after Day 3 Single Embryo Transfer
A 31 year-old woman had a single embryo transfer on day 3 after assisted hatching (AH) and intracytoplasmic sperm injection (ICSI) treatment. Ultrasound examination performed 6 weeks after oocyte retrieval revealed a tri...
Prenatal Outcomes of Monochorionic Pregnancies: Complications, Management and Morbility
Objective: The objetive in this study was to evaluate the incidence and complications of monochorionic twin. Material and Methods: A retrospective study of 32 pregnancies twins monochorionic, a total of 8000 births, cont...
Inherited and Acquired Thrombophilia and Infertility in a Population of Brazilian Women
Objective: To evaluate the relationship between thrombophilia and infertility Design: Cross-sectional study Setting: Assisted fertilization center Patients: The infertile women (n=130) selected were receiving care at a p...
Mifepristone Plus Vaginal Misoprostol V/S Vaginal Misoprostol Alone for Medical Termination of Pregnancy
Medical abortion has been investigated as a non-invasive option for early abortions as it avoids the risk of anesthesia and surgical trauma to the cervix, uterus and other organs. The main aim of the study was to compare...
Unilateral Labial Hypertrophy in Adolescents: when should we Interfere? Two Case Reports
Synopsis: Adolescent and pre-menarchal patients with symptomatic unilateral labial hypertrophy should be counselled extensively prior to surgical management regarding risks of recurrence or contralateral occurrence. Purp...